You have 9 free searches left this month | for more free features.

Malignancies

Showing 1 - 25 of 6,741

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prevelance Of Cutaneous Disorders Among Heamatologic

Not yet recruiting
  • Dermatologic Disorders With Heamatologic Malignancies Patients
  • cbc ,u\s renalor hepatic function test if needed
  • Sohag, Egypt
    Sohag university Hospital
Oct 25, 2023

Quality of Life After Gynacological Malignancies

Not yet recruiting
  • Gynecologic Cancer
  • Evaluate quality of life after gynaecological malignancies diagnosis and treatment
  • (no location specified)
Jan 11, 2023

CAR-T Treatment for Hematological Malignancies

Recruiting
  • Hematological Malignancies
  • Chimeric Antigen Receptor T-cell Therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 11, 2023

    Immunotherapy-related CRP Kinetics in Metastatic Gynecological

    Recruiting
    • Gynecological Malignancies
    • +4 more
      • Tuebingen, Germany
        Department of Women's Health
      Jun 13, 2023

      CD19-positive Relapsed or Refractory B-cell Malignancies Trial in Hefei (UTAA09 cells for infusion, Fludarabine,

      Not yet recruiting
      • CD19-positive Relapsed or Refractory B-cell Malignancies
      • UTAA09 cells for infusion
      • +2 more
      • Hefei, Anhui, China
        The First Affiliated Hospital of USTC (AnHui Provincial Hospital
      Oct 13, 2023

      Advanced Malignancies Trial in Guangzhou (BRY812 for injection)

      Not yet recruiting
      • Advanced Malignancies
      • BRY812 for injection
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital,Sun Yat-sen University
      Sep 7, 2023

      Hematological Malignancies Trial in Limoges ("Blend of ginger and lemon essential oils", "Neutral oil")

      Not yet recruiting
      • Hematological Malignancies
      • "Blend of ginger and lemon essential oils", "Neutral oil"
      • Limoges, France
        University Hospital, Limoges
      Nov 20, 2023

      Gynecological Malignancies Trial in Beijing (BL-M07D1)

      Not yet recruiting
      • Gynecological Malignancies
      • Beijing, Beijing, China
        Cancer Hospital, Chinese Academy of Medical Sciences
      Nov 15, 2023

      Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

      Recruiting
      • Myeloid Malignancies
      • fractionated busulfan-based conditioning regimen
      • Chendu, Sichuan, China
        West China Hospital, Sichuan University
      Mar 29, 2023

      Solid Malignancies Trial (Tisotumab Vedotin)

      Not yet recruiting
      • Solid Malignancies
      • Tisotumab Vedotin
      • (no location specified)
      May 9, 2023

      Advanced Solid Malignancies Trial in Irving (GIM122)

      Not yet recruiting
      • Advanced Solid Malignancies
      • Irving, Texas
        NEXT Dallas
      Sep 8, 2023

      Relapsed/Refractory B-cell Malignancies Trial (AC676)

      Not yet recruiting
      • Relapsed/Refractory B-cell Malignancies
      • (no location specified)
      Mar 27, 2023

      B-cell Lymphoid Malignancies Trial (ESG206)

      Not yet recruiting
      • B-cell Lymphoid Malignancies
      • (no location specified)
      Apr 10, 2023

      Gynaecological Malignancies Trial (SHR- A1811)

      Not yet recruiting
      • Gynaecological Malignancies
      • SHR- A1811
      • (no location specified)
      Jun 8, 2023

      Advanced Cancer Trial (AB801, Zimberelimab, Docetaxel)

      Not yet recruiting
      • Advanced Cancer
      • (no location specified)
      Nov 1, 2023

      Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

      Recruiting
      • Lymphoma
      • +4 more
      • Vysis LSI MYC Break Apart Rearrangement Probe Kit
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Relapsed/Refractory Aggressive B-Cell Malignancies Trial (ONCT-808, Bridging Therapy)

      Not yet recruiting
      • Relapsed/Refractory Aggressive B-Cell Malignancies
      • ONCT-808
      • Bridging Therapy
      • (no location specified)
      Jan 19, 2023

      B-Cell Malignancies Trial (TT-01488 Tablets)

      Not yet recruiting
      • B-Cell Malignancies
      • TT-01488 Tablets
      • (no location specified)
      Jan 4, 2023

      Hematological Malignancies Trial in Tianjin (ICP-248)

      Not yet recruiting
      • Hematological Malignancies
      • Tianjin, Tianjin, China
        Hematology Hospital, Chinese Academy of Medical Sciences
      Feb 13, 2023

      Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

      Recruiting
      • Hematologic Malignancies
      • RD13-02 cell infusion
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      Jun 26, 2023

      Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD2014)

      Active, not recruiting
      • Advanced Solid Malignancies
      • Chuo-ku, Japan
      • +1 more
      Feb 2, 2023

      Relmacabtagene Autoleucel in Hematologic Malignancies

      Not yet recruiting
      • Lymphoma, B-Cell
      • +2 more
      • Relmacabtagene Autoleucel
      • Beijing, Beijing, China
      • +1 more
      Nov 15, 2023

      Chemo-induced Thrombocytopenia Trial (Hetrombopag)

      Not yet recruiting
      • Chemotherapy-induced Thrombocytopenia
      • (no location specified)
      Oct 20, 2023

      B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

      Recruiting
      • B Cell Malignancies
      • Universal CD19-specific CAR gene-engineered T cells
      • Beijing, Beijing, China
      • +2 more
      Aug 8, 2023

      Advanced Malignant Cancer Trial (HRS-7053 Injection)

      Not yet recruiting
      • Advanced Malignant Cancer
      • HRS-7053 Injection
      • (no location specified)
      Aug 7, 2023